source name	characteristics[organism]	characteristics[organism part]	characteristics[organism part]	characteristics[brodmann area]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[developmental stage]	characteristics[BRAAK]	characteristics[PMD]	characteristics[biological replicate]	characteristics[Amyloid stage]	characteristics[individual]	assay name	technology type	comment[proteomexchange accession number]	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[cleavage agent details]	comment[label]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[technical replicate]	factor value[disease]	factor value[sex]
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 1	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 2	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 3	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 4	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 5	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 5	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 5	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 5	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 5	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 5	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 5	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 5	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 5	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 5	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 6	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 6	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 6	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 6	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 6	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 6	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 6	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 6	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 6	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 6	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 7	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 7	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 7	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 7	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 7	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 7	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 7	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 7	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 7	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 7	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 8	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 8	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 8	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 8	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 8	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 8	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 8	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 8	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 8	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 8	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 9	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 9	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 9	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 9	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 9	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 9	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 9	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 9	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 9	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 9	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 10	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 10	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 10	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 10	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 10	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 10	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 10	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 10	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 10	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 10	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 11	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 11	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 11	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 11	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 11	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 11	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 11	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 11	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 11	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 11	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 12	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 12	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 12	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 12	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 12	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 12	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 12	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 12	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 12	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 12	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 13	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 13	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 13	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 13	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 13	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 13	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 13	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 13	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 13	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 13	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 14	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 14	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 14	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 14	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 14	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 14	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 14	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 14	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 14	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 14	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 15	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 15	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 15	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 15	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 15	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 15	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 15	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 15	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 15	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 15	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 16	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 16	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 16	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 16	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 16	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 16	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 16	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 16	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 16	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 16	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 17	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 17	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 17	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 17	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 17	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 17	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 17	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 17	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 17	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 17	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 18	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 18	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 18	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 18	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 18	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 18	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 18	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 18	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 18	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 18	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 19	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 19	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 19	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 19	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 19	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 19	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 19	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 19	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 19	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 19	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 20	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 20	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 20	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 20	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 20	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 20	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 20	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 20	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 20	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 20	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 21	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 21	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 21	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 21	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 21	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 21	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 21	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 21	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 21	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 21	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 22	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 22	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 22	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 22	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 22	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 22	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 22	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 22	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 22	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 22	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 23	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 23	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 23	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 23	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 23	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 23	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 23	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 23	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 23	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 23	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 24	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 24	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 24	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 24	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 24	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 24	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 24	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 24	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 24	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 24	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 25	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 25	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 25	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 25	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 25	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 25	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 25	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 25	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 25	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 25	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 26	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 26	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 26	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 26	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 26	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 26	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 26	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 26	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 26	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 26	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 27	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 27	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 27	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 27	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 27	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 27	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 27	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 27	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 27	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 27	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 28	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 28	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 28	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 28	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 28	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 28	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 28	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 28	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 28	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 28	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 29	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 29	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 29	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 29	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 29	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 29	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 29	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 29	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 29	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 29	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 30	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 30	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 30	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 30	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 30	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 30	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 30	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 30	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 30	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 30	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 31	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 31	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 31	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 31	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 31	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 31	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 31	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 31	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 31	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 31	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 32	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 32	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 32	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 32	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 32	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 32	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 32	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 32	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 32	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 32	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 33	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 33	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 33	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 33	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 33	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 33	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 33	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 33	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 33	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 33	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 34	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 34	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 34	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 34	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 34	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 34	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 34	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 34	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 34	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 34	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 35	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 35	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 35	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 35	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 35	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 35	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 35	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 35	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 35	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 35	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 36	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 36	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 36	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 36	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 36	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 36	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 36	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 36	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 36	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 36	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 37	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 37	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 37	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 37	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 37	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 37	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 37	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 37	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 37	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 37	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 38	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 38	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 38	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 38	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 38	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 38	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 38	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 38	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 38	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 38	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 39	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 39	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 39	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 39	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 39	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 39	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 39	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 39	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 39	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 39	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 40	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 40	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 40	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 40	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 40	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 40	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 40	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 40	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 40	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 40	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 41	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 41	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 41	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 41	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 41	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 41	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 41	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 41	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 41	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 41	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 42	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 42	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 42	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 42	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 42	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 42	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 42	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 42	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 42	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 42	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 43	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 43	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 43	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 43	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 43	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 43	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 43	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 43	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 43	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 43	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 44	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 44	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 44	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 44	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 44	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 44	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 44	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 44	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 44	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 44	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 45	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 45	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 45	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 45	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 45	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 45	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 45	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 45	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 45	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 45	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 46	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 46	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 46	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 46	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 46	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 46	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 46	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 46	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 46	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 46	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 47	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 47	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 47	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 47	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 47	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 47	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 47	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 47	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 47	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 47	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 48	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 48	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 48	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 48	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 48	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 48	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 48	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 48	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 48	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 48	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 49	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 49	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 49	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 49	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 49	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 49	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 49	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 49	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 49	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 49	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 50	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 50	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 50	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 50	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 50	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 50	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 50	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 50	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 50	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 50	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 51	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 51	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 51	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 51	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 51	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 51	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 51	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 51	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 51	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 51	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 52	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 52	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 52	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 52	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 52	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 52	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 52	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 52	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 52	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 52	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 53	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 53	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 53	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 53	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 53	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 53	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 53	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 53	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 53	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 53	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 54	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 54	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 54	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 54	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 54	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 54	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 54	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 54	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 54	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 54	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 55	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 55	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 55	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 55	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 55	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 55	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 55	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 55	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 55	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 55	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 56	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 56	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 56	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 56	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 56	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 56	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 56	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 56	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 56	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 56	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 57	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 57	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 57	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 57	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 57	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 57	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 57	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 57	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 57	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 57	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 58	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 58	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 58	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 58	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 58	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 58	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 58	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 58	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 58	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 58	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 59	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 59	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 59	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 59	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 59	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 59	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 59	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 59	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 59	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 59	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 60	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 60	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 60	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 60	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 60	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 60	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 60	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 60	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 60	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 60	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 61	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 61	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 61	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 61	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 61	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 61	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 61	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 61	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 61	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 61	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 62	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 62	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 62	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 62	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 62	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 62	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 62	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 62	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 62	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 62	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 63	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 63	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 63	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 63	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 63	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 63	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 63	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 63	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 63	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 63	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 64	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 64	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 64	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 64	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 64	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 64	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 64	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 64	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 64	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 64	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 65	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 65	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 65	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 65	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 65	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 65	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 65	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 65	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 65	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 65	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 66	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 66	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 66	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 66	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 66	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 66	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 66	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 66	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 66	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 66	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 67	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 67	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 67	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 67	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 67	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 67	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 67	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 67	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 67	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 67	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 68	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 68	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 68	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 68	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 68	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 68	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 68	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 68	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 68	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 68	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 69	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 69	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 69	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 69	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 69	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 69	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 69	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 69	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 69	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 69	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 70	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 70	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 70	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 70	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 70	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 70	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 70	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 70	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 70	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 70	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 71	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 71	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 71	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 71	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 71	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 71	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 71	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 71	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 71	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 71	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD1	run 72	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Dementia with Lewy bodies	not available	3	4.5	1	not available	DLB1	run 72	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Dementia with Lewy bodies	not available	3	25.5	1	not available	DLB2	run 72	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	1	Dementia with Lewy bodies	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	72	not available	male	Parkinson's disease with dementia	not available	1	9	1	not available	PDD1	run 72	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	1	Parkinson's disease with dementia	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	79	not available	male	Normal	not available	0	34	1	not available	Ctrl1	run 72	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	1	Normal	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Normal	not available	0	22	1	not available	Ctrl2	run 72	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	1	Normal	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	75	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD2	run 72	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	1	Parkinson's disease with dementia	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Alzheimer's disease	not available	6	10	1	not available	AD1	run 72	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	1	Alzheimer's disease	male
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	4	24.5	1	not available	AD2	run 72	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	1	Alzheimer's disease	female
PXD006122-Sample-1	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD2	run 72	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset1_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	1	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 73	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 73	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 73	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 73	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 73	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 73	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 73	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 73	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 73	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 73	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 74	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 74	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 74	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 74	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 74	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 74	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 74	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 74	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 74	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 74	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 75	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 75	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 75	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 75	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 75	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 75	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 75	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 75	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 75	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 75	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 76	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 76	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 76	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 76	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 76	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 76	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 76	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 76	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 76	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 76	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 77	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 77	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 77	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 77	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 77	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 77	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 77	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 77	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 77	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 77	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 78	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 78	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 78	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 78	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 78	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 78	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 78	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 78	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 78	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 78	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 79	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 79	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 79	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 79	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 79	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 79	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 79	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 79	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 79	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 79	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 80	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 80	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 80	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 80	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 80	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 80	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 80	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 80	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 80	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 80	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 81	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 81	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 81	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 81	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 81	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 81	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 81	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 81	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 81	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 81	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 82	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 82	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 82	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 82	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 82	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 82	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 82	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 82	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 82	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 82	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 83	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 83	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 83	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 83	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 83	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 83	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 83	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 83	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 83	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 83	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 84	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 84	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 84	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 84	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 84	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 84	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 84	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 84	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 84	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 84	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 85	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 85	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 85	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 85	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 85	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 85	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 85	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 85	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 85	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 85	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 86	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 86	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 86	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 86	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 86	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 86	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 86	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 86	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 86	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 86	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 87	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 87	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 87	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 87	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 87	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 87	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 87	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 87	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 87	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 87	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 88	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 88	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 88	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 88	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 88	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 88	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 88	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 88	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 88	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 88	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 89	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 89	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 89	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 89	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 89	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 89	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 89	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 89	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 89	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 89	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 90	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 90	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 90	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 90	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 90	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 90	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 90	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 90	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 90	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 90	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 91	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 91	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 91	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 91	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 91	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 91	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 91	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 91	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 91	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 91	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 92	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 92	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 92	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 92	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 92	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 92	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 92	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 92	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 92	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 92	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 93	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 93	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 93	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 93	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 93	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 93	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 93	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 93	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 93	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 93	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 94	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 94	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 94	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 94	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 94	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 94	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 94	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 94	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 94	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 94	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 95	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 95	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 95	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 95	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 95	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 95	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 95	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 95	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 95	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 95	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 96	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 96	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 96	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 96	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 96	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 96	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 96	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 96	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 96	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 96	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 97	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 97	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 97	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 97	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 97	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 97	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 97	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 97	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 97	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 97	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 98	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 98	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 98	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 98	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 98	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 98	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 98	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 98	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 98	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 98	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 99	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 99	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 99	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 99	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 99	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 99	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 99	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 99	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 99	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 99	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 100	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 100	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 100	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 100	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 100	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 100	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 100	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 100	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 100	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 100	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 101	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 101	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 101	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 101	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 101	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 101	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 101	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 101	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 101	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 101	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 102	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 102	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 102	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 102	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 102	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 102	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 102	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 102	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 102	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 102	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 103	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 103	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 103	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 103	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 103	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 103	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 103	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 103	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 103	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 103	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 104	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 104	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 104	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 104	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 104	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 104	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 104	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 104	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 104	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 104	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 105	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 105	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 105	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 105	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 105	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 105	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 105	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 105	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 105	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 105	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 106	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 106	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 106	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 106	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 106	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 106	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 106	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 106	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 106	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 106	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 107	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 107	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 107	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 107	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 107	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 107	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 107	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 107	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 107	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 107	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 108	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 108	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 108	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 108	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 108	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 108	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 108	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 108	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 108	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 108	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 109	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 109	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 109	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 109	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 109	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 109	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 109	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 109	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 109	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 109	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 110	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 110	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 110	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 110	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 110	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 110	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 110	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 110	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 110	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 110	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 111	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 111	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 111	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 111	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 111	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 111	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 111	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 111	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 111	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 111	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 112	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 112	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 112	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 112	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 112	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 112	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 112	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 112	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 112	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 112	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 113	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 113	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 113	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 113	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 113	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 113	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 113	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 113	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 113	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 113	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 114	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 114	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 114	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 114	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 114	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 114	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 114	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 114	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 114	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 114	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 115	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 115	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 115	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 115	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 115	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 115	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 115	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 115	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 115	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 115	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 116	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 116	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 116	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 116	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 116	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 116	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 116	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 116	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 116	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 116	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 117	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 117	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 117	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 117	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 117	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 117	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 117	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 117	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 117	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 117	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 118	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 118	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 118	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 118	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 118	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 118	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 118	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 118	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 118	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 118	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 119	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 119	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 119	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 119	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 119	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 119	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 119	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 119	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 119	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 119	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 120	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 120	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 120	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 120	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 120	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 120	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 120	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 120	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 120	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 120	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 121	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 121	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 121	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 121	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 121	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 121	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 121	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 121	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 121	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 121	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 122	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 122	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 122	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 122	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 122	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 122	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 122	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 122	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 122	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 122	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 123	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 123	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 123	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 123	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 123	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 123	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 123	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 123	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 123	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 123	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 124	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 124	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 124	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 124	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 124	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 124	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 124	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 124	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 124	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 124	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 125	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 125	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 125	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 125	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 125	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 125	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 125	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 125	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 125	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 125	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 126	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 126	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 126	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 126	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 126	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 126	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 126	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 126	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 126	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 126	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 127	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 127	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 127	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 127	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 127	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 127	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 127	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 127	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 127	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 127	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 128	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 128	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 128	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 128	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 128	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 128	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 128	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 128	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 128	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 128	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 129	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 129	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 129	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 129	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 129	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 129	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 129	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 129	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 129	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 129	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 130	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 130	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 130	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 130	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 130	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 130	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 130	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 130	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 130	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 130	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 131	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 131	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 131	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 131	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 131	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 131	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 131	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 131	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 131	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 131	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 132	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 132	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 132	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 132	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 132	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 132	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 132	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 132	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 132	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 132	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 133	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 133	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 133	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 133	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 133	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 133	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 133	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 133	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 133	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 133	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 134	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 134	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 134	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 134	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 134	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 134	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 134	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 134	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 134	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 134	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 135	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 135	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 135	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 135	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 135	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 135	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 135	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 135	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 135	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 135	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 136	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 136	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 136	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 136	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 136	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 136	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 136	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 136	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 136	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 136	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 137	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 137	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 137	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 137	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 137	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 137	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 137	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 137	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 137	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 137	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 138	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 138	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 138	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 138	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 138	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 138	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 138	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 138	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 138	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 138	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 139	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 139	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 139	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 139	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 139	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 139	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 139	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 139	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 139	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 139	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 140	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 140	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 140	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 140	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 140	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 140	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 140	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 140	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 140	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 140	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 141	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 141	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 141	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 141	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 141	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 141	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 141	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 141	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 141	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 141	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 142	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 142	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 142	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 142	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 142	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 142	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 142	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 142	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 142	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 142	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 143	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 143	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 143	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 143	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 143	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 143	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 143	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 143	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 143	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 143	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD3	run 144	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Parkinson's disease with dementia	not available	2	33	1	not available	PDD3	run 144	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	male	Normal	not available	2	48	1	not available	Ctrl3	run 144	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	80	not available	female	Dementia with Lewy bodies	not available	4	29	1	not available	DLB3	run 144	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD4	run 144	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	2	Parkinson's disease with dementia	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	83	not available	male	Dementia with Lewy bodies	not available	3	38	1	not available	DLB4	run 144	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	2	Dementia with Lewy bodies	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Alzheimer's disease	not available	6	30	1	not available	AD3	run 144	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	male	Normal	not available	0	21.5	1	not available	Ctrl4	run 144	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	2	Normal	male
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Alzheimer's disease	not available	6	14	1	not available	AD4	run 144	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	2	Alzheimer's disease	female
PXD006122-Sample-2	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD4	run 144	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset2_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	2	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 145	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 145	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 145	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 145	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 145	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 145	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 145	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 145	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 145	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 145	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 146	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 146	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 146	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 146	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 146	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 146	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 146	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 146	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 146	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 146	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 147	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 147	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 147	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 147	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 147	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 147	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 147	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 147	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 147	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 147	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 148	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 148	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 148	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 148	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 148	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 148	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 148	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 148	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 148	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 148	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 149	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 149	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 149	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 149	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 149	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 149	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 149	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 149	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 149	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 149	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 150	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 150	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 150	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 150	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 150	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 150	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 150	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 150	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 150	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 150	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 151	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 151	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 151	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 151	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 151	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 151	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 151	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 151	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 151	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 151	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 152	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 152	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 152	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 152	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 152	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 152	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 152	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 152	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 152	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 152	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 153	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 153	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 153	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 153	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 153	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 153	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 153	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 153	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 153	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 153	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 154	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 154	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 154	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 154	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 154	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 154	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 154	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 154	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 154	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 154	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 155	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 155	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 155	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 155	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 155	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 155	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 155	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 155	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 155	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 155	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 156	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 156	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 156	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 156	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 156	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 156	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 156	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 156	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 156	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 156	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 157	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 157	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 157	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 157	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 157	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 157	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 157	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 157	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 157	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 157	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 158	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 158	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 158	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 158	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 158	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 158	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 158	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 158	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 158	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 158	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 159	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 159	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 159	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 159	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 159	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 159	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 159	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 159	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 159	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 159	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 160	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 160	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 160	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 160	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 160	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 160	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 160	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 160	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 160	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 160	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 161	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 161	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 161	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 161	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 161	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 161	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 161	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 161	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 161	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 161	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 162	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 162	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 162	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 162	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 162	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 162	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 162	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 162	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 162	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 162	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 163	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 163	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 163	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 163	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 163	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 163	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 163	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 163	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 163	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 163	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 164	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 164	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 164	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 164	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 164	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 164	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 164	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 164	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 164	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 164	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 165	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 165	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 165	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 165	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 165	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 165	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 165	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 165	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 165	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 165	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 166	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 166	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 166	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 166	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 166	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 166	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 166	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 166	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 166	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 166	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 167	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 167	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 167	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 167	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 167	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 167	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 167	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 167	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 167	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 167	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 168	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 168	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 168	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 168	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 168	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 168	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 168	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 168	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 168	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 168	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 169	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 169	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 169	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 169	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 169	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 169	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 169	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 169	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 169	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 169	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 170	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 170	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 170	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 170	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 170	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 170	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 170	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 170	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 170	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 170	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 171	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 171	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 171	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 171	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 171	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 171	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 171	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 171	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 171	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 171	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 172	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 172	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 172	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 172	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 172	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 172	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 172	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 172	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 172	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 172	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 173	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 173	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 173	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 173	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 173	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 173	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 173	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 173	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 173	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 173	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 174	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 174	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 174	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 174	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 174	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 174	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 174	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 174	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 174	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 174	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 175	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 175	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 175	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 175	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 175	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 175	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 175	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 175	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 175	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 175	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 176	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 176	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 176	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 176	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 176	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 176	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 176	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 176	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 176	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 176	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 177	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 177	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 177	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 177	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 177	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 177	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 177	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 177	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 177	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 177	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 178	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 178	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 178	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 178	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 178	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 178	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 178	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 178	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 178	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 178	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 179	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 179	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 179	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 179	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 179	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 179	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 179	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 179	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 179	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 179	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 180	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 180	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 180	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 180	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 180	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 180	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 180	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 180	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 180	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 180	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 181	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 181	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 181	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 181	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 181	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 181	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 181	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 181	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 181	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 181	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 182	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 182	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 182	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 182	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 182	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 182	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 182	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 182	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 182	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 182	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 183	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 183	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 183	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 183	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 183	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 183	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 183	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 183	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 183	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 183	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 184	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 184	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 184	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 184	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 184	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 184	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 184	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 184	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 184	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 184	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 185	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 185	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 185	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 185	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 185	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 185	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 185	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 185	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 185	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 185	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 186	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 186	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 186	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 186	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 186	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 186	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 186	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 186	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 186	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 186	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 187	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 187	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 187	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 187	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 187	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 187	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 187	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 187	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 187	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 187	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 188	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 188	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 188	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 188	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 188	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 188	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 188	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 188	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 188	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 188	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 189	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 189	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 189	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 189	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 189	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 189	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 189	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 189	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 189	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 189	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 190	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 190	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 190	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 190	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 190	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 190	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 190	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 190	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 190	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 190	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 191	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 191	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 191	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 191	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 191	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 191	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 191	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 191	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 191	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 191	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 192	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 192	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 192	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 192	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 192	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 192	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 192	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 192	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 192	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 192	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 193	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 193	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 193	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 193	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 193	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 193	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 193	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 193	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 193	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 193	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 194	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 194	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 194	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 194	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 194	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 194	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 194	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 194	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 194	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 194	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 195	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 195	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 195	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 195	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 195	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 195	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 195	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 195	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 195	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 195	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 196	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 196	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 196	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 196	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 196	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 196	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 196	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 196	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 196	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 196	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 197	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 197	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 197	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 197	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 197	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 197	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 197	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 197	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 197	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 197	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 198	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 198	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 198	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 198	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 198	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 198	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 198	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 198	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 198	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 198	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 199	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 199	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 199	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 199	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 199	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 199	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 199	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 199	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 199	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 199	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 200	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 200	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 200	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 200	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 200	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 200	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 200	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 200	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 200	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 200	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 201	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 201	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 201	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 201	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 201	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 201	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 201	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 201	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 201	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 201	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 202	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 202	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 202	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 202	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 202	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 202	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 202	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 202	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 202	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 202	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 203	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 203	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 203	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 203	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 203	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 203	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 203	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 203	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 203	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 203	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 204	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 204	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 204	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 204	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 204	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 204	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 204	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 204	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 204	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 204	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 205	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 205	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 205	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 205	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 205	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 205	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 205	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 205	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 205	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 205	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 206	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 206	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 206	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 206	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 206	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 206	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 206	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 206	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 206	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 206	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 207	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 207	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 207	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 207	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 207	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 207	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 207	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 207	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 207	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 207	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 208	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 208	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 208	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 208	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 208	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 208	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 208	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 208	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 208	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 208	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 209	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 209	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 209	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 209	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 209	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 209	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 209	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 209	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 209	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 209	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 210	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 210	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 210	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 210	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 210	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 210	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 210	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 210	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 210	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 210	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 211	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 211	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 211	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 211	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 211	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 211	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 211	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 211	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 211	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 211	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 212	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 212	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 212	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 212	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 212	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 212	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 212	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 212	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 212	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 212	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 213	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 213	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 213	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 213	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 213	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 213	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 213	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 213	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 213	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 213	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 214	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 214	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 214	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 214	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 214	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 214	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 214	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 214	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 214	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 214	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 215	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 215	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 215	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 215	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 215	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 215	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 215	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 215	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 215	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 215	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD5	run 216	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	84	not available	female	Dementia with Lewy bodies	not available	4	13.5	1	not available	DLB5	run 216	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	3	Dementia with Lewy bodies	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Parkinson's disease with dementia	not available	2	24	1	not available	PDD5	run 216	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	17.5	1	not available	AD5	run 216	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Dementia with Lewy bodies	not available	2	8	1	not available	DLB6	run 216	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	3	Dementia with Lewy bodies	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	82	not available	female	Normal	not available	0	43	1	not available	Ctrl5	run 216	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Alzheimer's disease	not available	6	29	1	not available	AD6	run 216	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	3	Alzheimer's disease	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	female	Normal	not available	2	6	1	not available	Ctrl6	run 216	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	3	Normal	female
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	86	not available	male	Parkinson's disease with dementia	not available	0	32	1	not available	PDD6	run 216	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	3	Parkinson's disease with dementia	male
PXD006122-Sample-3	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD6	run 216	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset3_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	3	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 217	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 217	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 217	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 217	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 217	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 217	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 217	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 217	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 217	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 217	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr01.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 218	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 218	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 218	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 218	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 218	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 218	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 218	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 218	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 218	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 218	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr02.raw	2	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 219	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 219	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 219	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 219	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 219	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 219	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 219	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 219	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 219	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 219	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr03.raw	3	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 220	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 220	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 220	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 220	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 220	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 220	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 220	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 220	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 220	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 220	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr04.raw	4	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 221	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 221	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 221	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 221	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 221	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 221	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 221	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 221	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 221	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 221	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr05.raw	5	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 222	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 222	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 222	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 222	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 222	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 222	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 222	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 222	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 222	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 222	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr06.raw	6	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 223	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 223	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 223	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 223	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 223	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 223	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 223	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 223	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 223	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 223	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr07.raw	7	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 224	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 224	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 224	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 224	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 224	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 224	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 224	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 224	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 224	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 224	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr08.raw	8	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 225	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 225	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 225	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 225	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 225	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 225	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 225	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 225	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 225	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 225	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr09.raw	9	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 226	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 226	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 226	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 226	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 226	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 226	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 226	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 226	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 226	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 226	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr10.raw	10	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 227	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 227	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 227	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 227	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 227	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 227	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 227	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 227	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 227	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 227	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr11.raw	11	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 228	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 228	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 228	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 228	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 228	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 228	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 228	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 228	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 228	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 228	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr12.raw	12	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 229	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 229	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 229	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 229	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 229	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 229	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 229	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 229	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 229	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 229	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr13.raw	13	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 230	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 230	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 230	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 230	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 230	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 230	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 230	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 230	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 230	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 230	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr14.raw	14	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 231	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 231	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 231	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 231	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 231	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 231	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 231	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 231	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 231	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 231	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr15.raw	15	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 232	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 232	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 232	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 232	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 232	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 232	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 232	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 232	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 232	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 232	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr16.raw	16	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 233	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 233	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 233	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 233	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 233	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 233	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 233	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 233	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 233	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 233	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr17.raw	17	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 234	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 234	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 234	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 234	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 234	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 234	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 234	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 234	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 234	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 234	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr18.raw	18	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 235	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 235	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 235	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 235	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 235	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 235	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 235	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 235	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 235	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 235	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr19.raw	19	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 236	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 236	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 236	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 236	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 236	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 236	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 236	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 236	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 236	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 236	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr20.raw	20	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 237	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 237	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 237	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 237	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 237	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 237	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 237	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 237	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 237	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 237	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr21.raw	21	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 238	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 238	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 238	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 238	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 238	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 238	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 238	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 238	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 238	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 238	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr22.raw	22	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 239	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 239	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 239	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 239	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 239	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 239	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 239	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 239	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 239	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 239	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr23.raw	23	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 240	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 240	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 240	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 240	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 240	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 240	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 240	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 240	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 240	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 240	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr24.raw	24	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 241	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 241	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 241	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 241	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 241	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 241	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 241	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 241	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 241	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 241	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr25.raw	25	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 242	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 242	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 242	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 242	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 242	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 242	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 242	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 242	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 242	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 242	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr26.raw	26	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 243	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 243	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 243	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 243	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 243	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 243	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 243	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 243	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 243	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 243	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr27.raw	27	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 244	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 244	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 244	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 244	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 244	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 244	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 244	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 244	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 244	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 244	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr28.raw	28	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 245	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 245	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 245	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 245	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 245	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 245	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 245	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 245	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 245	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 245	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr29.raw	29	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 246	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 246	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 246	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 246	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 246	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 246	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 246	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 246	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 246	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 246	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr30.raw	30	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 247	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 247	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 247	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 247	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 247	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 247	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 247	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 247	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 247	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 247	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr31.raw	31	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 248	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 248	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 248	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 248	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 248	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 248	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 248	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 248	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 248	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 248	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr32.raw	32	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 249	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 249	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 249	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 249	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 249	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 249	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 249	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 249	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 249	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 249	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr33.raw	33	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 250	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 250	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 250	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 250	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 250	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 250	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 250	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 250	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 250	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 250	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr34.raw	34	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 251	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 251	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 251	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 251	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 251	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 251	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 251	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 251	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 251	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 251	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr35.raw	35	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 252	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 252	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 252	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 252	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 252	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 252	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 252	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 252	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 252	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 252	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr36.raw	36	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 253	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 253	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 253	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 253	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 253	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 253	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 253	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 253	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 253	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 253	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr37.raw	37	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 254	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 254	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 254	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 254	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 254	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 254	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 254	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 254	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 254	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 254	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr38.raw	38	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 255	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 255	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 255	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 255	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 255	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 255	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 255	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 255	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 255	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 255	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr39.raw	39	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 256	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 256	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 256	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 256	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 256	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 256	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 256	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 256	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 256	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 256	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr40.raw	40	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 257	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 257	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 257	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 257	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 257	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 257	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 257	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 257	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 257	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 257	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr41.raw	41	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 258	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 258	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 258	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 258	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 258	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 258	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 258	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 258	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 258	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 258	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr42.raw	42	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 259	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 259	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 259	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 259	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 259	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 259	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 259	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 259	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 259	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 259	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr43.raw	43	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 260	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 260	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 260	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 260	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 260	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 260	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 260	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 260	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 260	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 260	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr44.raw	44	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 261	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 261	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 261	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 261	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 261	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 261	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 261	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 261	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 261	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 261	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr45.raw	45	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 262	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 262	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 262	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 262	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 262	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 262	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 262	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 262	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 262	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 262	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr46.raw	46	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 263	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 263	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 263	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 263	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 263	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 263	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 263	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 263	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 263	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 263	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr47.raw	47	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 264	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 264	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 264	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 264	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 264	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 264	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 264	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 264	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 264	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 264	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr48.raw	48	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 265	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 265	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 265	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 265	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 265	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 265	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 265	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 265	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 265	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 265	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr49.raw	49	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 266	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 266	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 266	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 266	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 266	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 266	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 266	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 266	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 266	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 266	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr50.raw	50	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 267	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 267	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 267	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 267	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 267	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 267	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 267	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 267	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 267	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 267	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr51.raw	51	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 268	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 268	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 268	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 268	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 268	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 268	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 268	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 268	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 268	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 268	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr52.raw	52	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 269	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 269	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 269	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 269	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 269	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 269	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 269	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 269	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 269	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 269	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr53.raw	53	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 270	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 270	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 270	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 270	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 270	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 270	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 270	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 270	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 270	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 270	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr54.raw	54	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 271	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 271	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 271	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 271	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 271	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 271	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 271	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 271	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 271	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 271	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr55.raw	55	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 272	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 272	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 272	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 272	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 272	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 272	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 272	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 272	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 272	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 272	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr56.raw	56	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 273	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 273	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 273	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 273	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 273	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 273	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 273	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 273	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 273	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 273	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr57.raw	57	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 274	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 274	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 274	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 274	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 274	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 274	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 274	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 274	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 274	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 274	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr58.raw	58	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 275	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 275	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 275	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 275	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 275	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 275	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 275	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 275	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 275	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 275	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr59.raw	59	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 276	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 276	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 276	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 276	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 276	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 276	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 276	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 276	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 276	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 276	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr60.raw	60	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 277	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 277	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 277	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 277	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 277	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 277	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 277	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 277	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 277	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 277	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr61.raw	61	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 278	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 278	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 278	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 278	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 278	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 278	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 278	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 278	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 278	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 278	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr62.raw	62	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 279	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 279	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 279	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 279	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 279	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 279	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 279	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 279	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 279	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 279	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr63.raw	63	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 280	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 280	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 280	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 280	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 280	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 280	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 280	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 280	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 280	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 280	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr64.raw	64	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 281	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 281	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 281	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 281	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 281	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 281	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 281	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 281	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 281	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 281	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr65.raw	65	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 282	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 282	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 282	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 282	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 282	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 282	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 282	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 282	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 282	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 282	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr66.raw	66	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 283	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 283	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 283	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 283	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 283	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 283	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 283	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 283	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 283	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 283	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr67.raw	67	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 284	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 284	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 284	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 284	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 284	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 284	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 284	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 284	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 284	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 284	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr68.raw	68	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 285	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 285	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 285	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 285	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 285	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 285	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 285	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 285	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 285	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 285	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr69.raw	69	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 286	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 286	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 286	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 286	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 286	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 286	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 286	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 286	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 286	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 286	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr70.raw	70	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 287	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 287	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 287	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 287	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 287	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 287	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 287	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 287	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 287	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 287	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr71.raw	71	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD7	run 288	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT126	10 ppm	0.02 Da	4	Internal standard	not available
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	5	44	1	not available	AD7	run 288	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127N	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	81	not available	male	Normal	not available	1	42	1	not available	Ctrl7	run 288	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT127C	10 ppm	0.02 Da	4	Normal	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	89	not available	female	Normal	not available	2	65	1	not available	Ctrl8	run 288	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128N	10 ppm	0.02 Da	4	Normal	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	87	not available	female	Dementia with Lewy bodies	not available	2	33.5	1	not available	DLB7	run 288	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT128C	10 ppm	0.02 Da	4	Dementia with Lewy bodies	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	male	Parkinson's disease with dementia	not available	2	24	1	not available	PDD7	run 288	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	male
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	85	not available	female	Alzheimer's disease	not available	6	20.45	1	not available	AD8	run 288	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT129C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Parkinson's disease with dementia	not available	2	32	1	not available	PDD8	run 288	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130N	10 ppm	0.02 Da	4	Parkinson's disease with dementia	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	88	not available	female	Alzheimer's disease	not available	6	24	1	not available	AD9	run 288	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT130C	10 ppm	0.02 Da	4	Alzheimer's disease	female
PXD006122-Sample-4	Homo sapiens	Brain	Prefrontal cortex	Brodmann area 9	not applicable	not available	not available	not available	Internal standard	not available	not available	not available	1	not available	INTSTD8	run 288	proteomic profiling by mass spectrometry	PXD006122	Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	https://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006122/Rui_Erika_Synaptic_Proteomics_BA9_TMTset4_250ug_IPG3-10_50min_10of15ul_fr72.raw	72	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	AC=MS:1001309;NT=Lys-C	TMT131	10 ppm	0.02 Da	4	Internal standard	not available